StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.82−0.12 (-4.08%)

Close on Nov 18, 2026Market cap $48.37MP/E –Yield –

Tonix Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Tonix Pharmaceuticals's total debt was $7.49M at Dec 31, 2024. For fiscal 2024 it was $7.49M, down 16.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$7.49M-16.0%
FY2023Dec 31, 2023$8.91M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$7.49M-16.0%
Q3 FY2024Sep 30, 2024$7.99M–
Q2 FY2024Jun 30, 2024$8.49M–
Q1 FY2024Mar 31, 2024$8.98M–
Q4 FY2023Dec 31, 2023$8.91M–

More Tonix Pharmaceuticals figures

See a number that looks wrong?